Natalia Lisiak
0000-0002-8793-6594
Publication & Citation Trends
Publications
0 total
Biotechnology Production of Cell Biomass from the Endangered Kickxia elatine (L.) Dumort: Its Untargeted Metabolomic Analysis and Cytotoxic Potential Against Melanoma Cells
Cited by 1
Semantic Scholar
Changes in Polyphenolic Profile and Antioxidant Properties of Selected Raw and Processed Vegetables Under Different Cooking Methods
Cited by 3
Semantic Scholar
Telomerase inhibitors TMPyP4 and BIBR 1532 show synergistic antitumor activity in combination with chemotherapeutic drugs
Cited by 0
Semantic Scholar
Corrigendum to "The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells" [Biomed. Pharmacother. 176 (2024) 116892].
Cited by 0
Semantic Scholar
Ionotropic Gelation and Chemical Crosslinking as Tools to Obtain Gellan Gum-Based Beads with Mesalazine
Cited by 1
Semantic Scholar
Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies OA
Cited by 12
Semantic Scholar
Cytotoxic effects of kinetin riboside and its selected analogues on cancer cell lines.
Cited by 3
Semantic Scholar
Evaluation of Cytotoxic Activity of Cell Biomass from Eryngium planum and Lychnis flos-cuculi on Melanoma Cancer Cell OA
Cited by 5
Semantic Scholar
The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells.
Cited by 7
Semantic Scholar
Human Vault RNAs: Exploring Their Potential Role in Cellular Metabolism OA
Cited by 8
Semantic Scholar
Research Topics
Natural product bioactivities and synthesis
(6)
Autophagy in Disease and Therapy
(5)
Telomeres, Telomerase, and Senescence
(5)
Phytochemicals and Antioxidant Activities
(3)
MicroRNA in disease regulation
(3)
Affiliations
Poznan University of Medical Sciences
Duke University
Korea University Medical Center
Vall d'Hebron Institut de Recerca
Vall d'Hebron Institute of Oncology